Small molecule for acute respiratory distress syndrome
Total Trials
9
As Lead Sponsor
2
As Collaborator
7
Total Enrollment
2,825
NCT03362684
PETACC-8 miR-31-3p and miR-31-5p Ancillary Study
Phase: Phase 3
Role: Collaborator
Start: Nov 30, 2005
Completion: Jun 30, 2016
NCT03328117
A Study to Investigate the Effects of Imatinib on Pulmonary Vascular Dysfunction in a Human Model of Lung Injury
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 13, 2017
Completion: Mar 5, 2018
NCT03798899
Efficacy and Safety of Penthrox® Combined With a Standard Analgesia (SoC) in Adult Patients Admitted to the Emergency Department With Moderate to Severe Pain Associated With Trauma
Phase: Phase 4
Start: May 14, 2018
Completion: Dec 20, 2018
NCT04794088
Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients
Phase: Phase 2
Start: Mar 14, 2021
Completion: Apr 7, 2022
NCT04953052
A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care.
Start: Oct 14, 2021
Completion: Nov 30, 2022
NCT05307874
Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors
Phase: Phase 1/2
Start: Apr 19, 2022
Completion: Dec 31, 2025
NCT06381024
A Study of Telemonitoring in Cancer Patients
Phase: N/A
Start: Apr 4, 2023
Completion: Dec 30, 2024
NCT06465472
Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3
Start: Aug 31, 2024
Completion: Aug 31, 2030
NCT06472245
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Start: Dec 3, 2024
Completion: Dec 15, 2028
Loading map...